Forensic toxicology

Detection of LSD-like substances 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD, and LSZ in blotter papers

Updated

Abstract

Four new have been identified in paper sheet products.

  • The analogs include 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD, and LSZ.
  • 1cP-AL-LAD and 1cP-MIPLA have structural modifications at multiple positions compared to LSD.
  • The metabolic pathways and biological activities of 1cP-AL-LAD and 1cP-MIPLA remain unreported.
  • This finding marks the first detection of such LSD analogs in Japan.
  • There is concern regarding the potential future distribution of these new LSD analogs.

Simplified

Key figures

Fig. 1
Chemical structures of LSD and seven related analog compounds.
Highlights structural variations in newly identified found in sheet drug products.
11419_2023_661_Fig1_HTML
  • Panels 1–8
    Chemical structures of LSD, 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD, LSZ, 1cP-LSD, and 1B-LSD are displayed with molecular bonds and atom positions.
Fig. 2
Chemical analysis of compound peak 1 from sheet A using LC-PDA-MS techniques
Highlights detailed chemical signatures of a newly identified LSD analog in using multiple analytical methods
11419_2023_661_Fig2_HTML
  • Panel a
    showing a peak at 15.94 minutes labeled as peak 1
  • Panel b
    Total ion chromatogram () with a peak at 15.97 minutes labeled as peak 1
  • Panel c
    of peak 1 with absorbance maxima at 255 nm and 294 nm
  • Panel d
    Electrospray ionization (ESI) mass spectrum of peak 1 showing a protonated molecular ion [H]+ at 418
Fig. 3
Gas chromatography-mass spectrometry data identifying a compound in sheet A
Highlights the detection and molecular signature of an LSD analog in sheet drug products using GC-MS analysis
11419_2023_661_Fig3_HTML
  • Panel a
    Total ion chromatogram () showing a prominent peak at 13.350 minutes labeled as peak 1
  • Panel b
    Electron ionization (EI) mass spectrum of peak 1 with a molecular ion peak (M+) at 417 and multiple fragment peaks
Fig. 4
and correlations of LSD analog molecules
Highlights detailed molecular connectivity in three , aiding their chemical identification.
11419_2023_661_Fig4_HTML
  • Panels 1–3
    Chemical structures of 1cP-AL-LAD, 1cP-MIPLA, and 1V-LSD with arrows indicating COSY (bold lines) and HMBC (curved arrows) correlations between atoms
Fig. 5
Chemical analysis of sheet B showing chromatograms, UV spectra, and mass spectra of two peaks
Highlights distinct chromatographic and spectral profiles for two compounds in sheet B, aiding identification of
11419_2023_661_Fig5_HTML
  • Panel a
    of sheet B with two labeled peaks, 2 at 13.70 min and 2b at 15.82 min
  • Panel b
    (total ion chromatogram) of sheet B showing peaks 2 at 13.74 min and 2b at 15.84 min
  • Panel c
    of peak 2 at 13.7 min with absorbance peaks near 229, 240, and 294 nm
  • Panel d
    UV spectrum of peak 2b at 15.8 min with absorbance peaks near 256 and 295 nm
  • Panel e
    of peak 2 at 13.7 min showing a major ion at 392 ([H]+)
  • Panel f
    ESI mass spectrum of peak 2b at 15.8 min showing a major ion at m/z 392 ([M+H]+)
1 / 5

Full Text

What this is

  • Four were identified from paper sheet products in Japan.
  • These compounds include 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD, and LSZ.
  • The study utilized various mass spectrometry techniques and NMR spectroscopy for identification.

Essence

  • New were detected in sheet products, indicating ongoing changes in the landscape of designer drugs. This study marks the first identification of with multiple structural modifications in Japan.

Key takeaways

  • 1cP-AL-LAD and 1cP-MIPLA were identified as modified at multiple positions. This finding raises concerns about the emergence of new psychoactive substances in the market.
  • The study emphasizes the importance of continuous monitoring for newly distributed to address potential health risks associated with these substances.

Caveats

  • The metabolic pathways and biological activities of the identified remain unreported, which limits understanding of their effects.
  • The study was conducted on products obtained within a specific timeframe, which may not represent the entire market.

Definitions

  • LSD analogs: Compounds structurally similar to lysergic acid diethylamide (LSD) that may have psychoactive effects.

Simplified

Funding

Competing interests

The authors declare that they have no conflict of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free